>Go!

Quarterly Results

Quarterly Results

Quarter Date Title
2Q '16 08.08.2016 Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion
08.08.2016Q2 2016 Allergan plc Earnings Conference Call
1Q '16 05.10.2016 Allergan Reports Strong First Quarter 2016 Continuing Operations Performance with 48% Increase in Net Revenue to $3.8 Billion and 15% Growth in Non-GAAP Diluted EPS to $3.04
05.10.2016Q1 2016 Allergan plc Earnings Conference Call
05.10.2016Q1 2016 Earnings Presentation (PDF)
4Q '15 02.22.2016 Allergan Reports Exceptional Fourth Quarter 2015 Continuing Operations Performance with 74% Increase in Net Revenue to $4.2 Billion and 33% Growth in Non-GAAP Diluted EPS to $3.41
02.22.2016Q4 2015 Allergan plc Earnings Conference Call
02.22.2016Q4 2015 Earnings Presentation (PDF)
3Q '15 11.04.2015 Allergan Reports Exceptional Third Quarter 2015 Continuing Operations Performance with 90% Increase in Net Revenue to $4.1 Billion and 65% Growth in Non-GAAP EPS to $3.48
11.04.2015Q3 2015 Allergan plc Earnings Conference Call
11.04.2015Q3 2015 Earnings Presentation (PDF)
2Q '15 08.06.2015 Allergan Reports Exceptional Second Quarter 2015 Performance with 116% Increase in Net Revenue to $5.76 Billion and 29% Growth in Non-GAAP EPS to $4.41
08.06.2015Q2 2015 Allergan plc Earnings Conference Call
08.06.2015Q2 2015 Earnings Presentation (PDF)
1Q '15 05.11.2015 Actavis Reports Exceptional Performance in First Quarter 2015 with 59% Increase in Net Revenue to $4.2 Billion and 23% Growth in Non-GAAP EPS to $4.30
05.11.2015Q1 2015 Actavis plc Earnings Conference Call
05.11.2015Q1 2015 Earnings Presentation (PDF)
4Q '14 02.18.2015 Actavis Non-GAAP Net Revenue Increases 44% to $4 Billion in Fourth Quarter 2014; Non-GAAP EPS Increases 23% to $3.91; Increases 2015 Standalone Forecast
02.18.2015Q4 Pro Forma Adjustments (PDF)
3Q '14 11.05.2014 Actavis Net Revenue Increases 83% to $3.7 Billion in Third Quarter 2014; Non-GAAP EPS Increases 53% to $3.19
11.05.2014Q3 2014 Actavis plc Earnings Conference Call
11.05.2014Q3 2014 Earnings Presentation (PDF)
11.05.2014Q3 Pro Forma Adjustments (PDF)
2Q '14 08.05.2014 Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42
08.05.2014Q2 2014 Actavis plc Earnings Conference Call
08.05.2014Q2 2014 Earnings Presentation (PDF)
08.05.2014Q2 Pro Forma Adjustments (PDF)
1Q '14 04.30.2014 Actavis Net Revenue Increases 40% to $2.66 Billion in First Quarter 2014; Non-GAAP EPS Increases 75% to $3.49
04.30.2014Q1 2014 Actavis plc Earnings Conference Call
04.30.2014Q1 Pro Forma Adjustments (PDF)
05.06.2014Actavis Pharma Segment Revenue Recasting
Page 1 of 3